comparemela.com

Latest Breaking News On - Fosun kite biotechnology - Page 1 : comparemela.com

Big Pharma must sacrifice upfront profits to get on China s coveted list of medicines eligible for insurance reimbursements

The NRDL, a compilation that has existed for two decades, is part of the Chinese government’s plan to make health care affordable and accessible under the country’s socialist principles. Formally adopted in 2017 as an annual list, it forms part of the “common prosperity” aspiration pledged by President Xi Jinping.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.